Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation
| Image |  |
|---|---|
| Description | scientific article published on 04 December 2018 |
| Author/s |
author: Vassiliki Papadimitrakopoulou |
| Publication date | December 4, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |